Szpital Ruber Internacional
Sarcoma treatment cost in Spain typically involves a PET-CT scan running from $1,300 to $1,800 and primary Sarcoma surgery ranging from $31,400 to $40,000. Total expenses depend on tumor stage, surgical complexity, and the need for advanced radiotherapy. Patients often see 30-50% savings compared to the US. Top treatment hubs include Barcelona, Madrid, and Pamplona.
Typical Sarcoma Treatment Costs in Spain
Bookimed Expert Insight: Patients seeking limb preservation should prioritize specialized centers like Clinica Universidad de Navarra. They report a 95% limb preservation rate and a 74% cure rate for bone sarcomas. Pediatric cases are best managed at SJD Barcelona Children's Hospital, a top-ranked European institution. For advanced radiation, Quironsalud Madrid offers Spain's first proton therapy center for precise tumor targeting.
| Turcja | Austria | Hiszpania | |
| Zogniskowana ablacja ultradźwiękowa (HIFU) | od $4,000 | od $12,000 | od $6,000 |
| Terapia protonowa w raku prostaty | od $30,000 | od $80,000 | od $70,000 |
| Terapia protonowa przy raku piersi | od $30,000 | od $55,000 | od $85,000 |
| Terapia protonowa | od $70,000 | od $80,000 | od $25,547 |
| Radioterapia raka odbytnicy | od $7,000 | od $12,000 | od $10,000 |
Kierownik oddziału mięsaków w Centrum Medycznym Teknon — dr Galceran przeprowadził ponad 1200 zabiegów leczenia mięsaków.
Uznany onkolog dziecięcy specjalizujący się w mięsakach kości i tkanek miękkich. Kieruje Oddziałem Hematologii i Onkologii w szpitalu dziecięcym SJD Barcelona — jednej z najlepszych placówek w Europie.
Specjalista chirurgii ortopedycznej i traumatologii, koncentrujący się na leczeniu mięsaków w Clinica Universidad de Navarra.
Dr López-Ibor specjalizuje się w hematologii i onkologii dziecięcej. Posiada ponad 20-letnie doświadczenie i kieruje Oddziałem Hematologii i Onkologii Dziecięcej w szpitalu HM Montepríncipe.
Top sarcoma hospitals in Spain include Clinica Universidad de Navarra and Centro Medico Teknon. These JCI-accredited centers specialize in complex bone and soft tissue tumors. They use advanced methods like proton therapy and limb-sparing surgery. Treatment focus includes high survival and function preservation.
Bookimed Expert Insight: Quality is consistent across major cities, but speed of access varies. Clinica Universidad de Navarra in Pamplona maintains a high 74% bone sarcoma cure rate. Meanwhile, Barcelona centers like Teknon offer rapid multidisciplinary coordination. Selecting a center with GEIS affiliation ensures access to the latest Spanish sarcoma clinical trials.
Patient Consensus: Patients emphasize finding a doctor who reviews documentation thoroughly before the first visit. They note that specialized units are often more efficient than large, general hospitals for scheduling.
Initial consultations should focus on subtype identification and multidisciplinary care. Ask about the precise sarcoma grade and mitotic rate. Confirm if genomic testing is required for targeted therapy. Ask about your specific risk profiles for limb-sparing surgery and long-term functional survival outcomes.
Bookimed Expert Insight: Spanish centers like Clinica Universidad de Navarra maintain a 95% limb preservation rate. This far exceeds general oncology averages. When consulting, ask your surgeon if they utilize high intensity focused ultrasound or specialized implants. Our data shows these leading centers focus heavily on functional recovery alongside a 74% bone sarcoma cure rate.
Patient Consensus: Patients note it's important to request a full pathology report including molecular markers like MDM2. Many recommend staying at JCI-accredited facilities in Barcelona or Madrid for faster scan turnaround times compared to public systems.
Spanish specialized centers report a 95% limb preservation rate for bone sarcomas. Expert units achieve a 74% average cure rate. Patients treated in designated high-volume facilities see an 82% 5-year survival rate. Advanced techniques like 3D custom implants and proton therapy drive these outcomes.
Bookimed Expert Insight: Clinica Universidad de Navarra demonstrates the value of massive patient volumes. They have treated 700,000 patients from 70 countries. This global experience contributes to their 74% 10-year survival rate for osteosarcoma. High-volume centers like this offer more specialized procedures such as mega-prostheses limb salvage.
Patient Consensus: Patients emphasize that early multidisciplinary tumor board reviews significantly improve the chances of saving a limb. Many note that choosing centers with 3D custom implant programs leads to much better post-op mobility.